MedPath

Growth and Tolerance of Cow's Milk-Based Infant Formulas

Not Applicable
Completed
Conditions
Growth
Interventions
Other: Previously marketed infant formula
Other: Previously marketed formula using a similar protein
Registration Number
NCT02481531
Lead Sponsor
Mead Johnson Nutrition
Brief Summary

This clinical trial will evaluate the growth, tolerance, and iron status of infants who consume an investigational infant formula containing a nutrient-rich whey protein compared to a previously marketed infant formula.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
373
Inclusion Criteria
  • Singleton, 10-14 days of age at randomization
  • Term infant with birth weight of a minimum of 2500 grams
  • Solely formula fed
  • Signed Informed Consent and Protected Health Information
Exclusion Criteria
  • Anemia at time of birth
  • Current use of iron or iron-containing supplements
  • History of underlying metabolic or chronic disease or immunocompromised
  • Feeding difficulties or formula intolerance

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Previously marketed infant formulaPreviously marketed infant formulaCow's milk-based infant formula
Previously marketed formula using a similar proteinPreviously marketed formula using a similar proteinCow's milk-based infant formula
Primary Outcome Measures
NameTimeMethod
Body weight measured at each study visit12 months

Measurement collected with a calibrated infant scale

Secondary Outcome Measures
NameTimeMethod
Body length measured at each study visit12 months

Measurement collected with a standardized length board

Head circumference measured at each study visit12 months

Measurement collected with a standardized measuring tape

Parental recall of study formula intake at each study visit12 months
Parental recall of stool consistency measured at each study visit12 months
Blood CollectionOnce at 12 months

Composite measure of hemoglobin, hematocrit, ferritin, and c-reactive protein

Medically-confirmed adverse events collected throughout the study period12 months

Trial Locations

Locations (20)

The Children's Clinic of Jonesboro, P.A.

🇺🇸

Jonesboro, Arkansas, United States

The Jackson Clinic - North Jackson

🇺🇸

Jackson, Tennessee, United States

Holston Medical Group

🇺🇸

Kingsport, Tennessee, United States

Owensboro Pediatrics

🇺🇸

Owensboro, Kentucky, United States

DCOL Center for Clinical Research

🇺🇸

Longview, Texas, United States

Children's Research, LLC

🇺🇸

Altamonte Springs, Florida, United States

Coastal Pediatric Research

🇺🇸

Charleston, South Carolina, United States

Birmingham Pediatric Associates

🇺🇸

Birmingham, Alabama, United States

Northwest Arkansas Pediatric Clinic

🇺🇸

Fayetteville, Arkansas, United States

Southeastern Pediatric Associates

🇺🇸

Dothan, Alabama, United States

Pediatrics East - Alabama Clinical Therapeutics

🇺🇸

Pinson, Alabama, United States

Kentucky Pediatrics/Adult Research

🇺🇸

Bardstown, Kentucky, United States

Norwich Pediatric Group, P.C.

🇺🇸

Norwich, Connecticut, United States

Deaconess Clinical Research

🇺🇸

Evansville, Indiana, United States

Heartland Research Associates, LLC

🇺🇸

Wichita, Kansas, United States

Pediatric Associates of Fairfield, Inc.

🇺🇸

Fairfield, Ohio, United States

Pediatric Associates of Mt. Carmel, Inc

🇺🇸

Cincinnati, Ohio, United States

UHMP Comprehensive Pediatrics

🇺🇸

Westlake, Ohio, United States

Woburn Pediatic Associates

🇺🇸

Woburn, Massachusetts, United States

Ohio Pediatric Research Association

🇺🇸

Dayton, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath